Lumason
Sponsors
Bracco Diagnostics, Inc, Children's Hospital of Philadelphia, David Mooney, University of California, Los Angeles, Boston Children's Hospital
Conditions
Abdominal InjuryAlzheimer Disease, Early OnsetBrain TumorBreast CancerContrast Enhanced UltrasoundCoronary Artery DiseaseDevelopmental Dysplasia of the HipGBM
Early Phase 1
Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDH
RecruitingNCT03107520
Start: 2017-05-22End: 2030-04-30Target: 125Updated: 2025-04-17
Study: SONAS Ultrasound for Detecting Stroke SONAS Ultrasound for Detecting Stroke
CompletedNCT03296852
Start: 2018-04-19End: 2019-01-20Updated: 2019-03-26
Comparison of Three Methods for Early Detection of Breast Cancer
CompletedNCT03954015
Start: 2019-10-15End: 2021-10-05Updated: 2022-01-10
Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).
WithdrawnNCT05957042
Start: 2023-09-01End: 2031-09-01Updated: 2025-12-10
Phase 1
Contrast-Enhanced Ultrasound in the Evaluation of Abdominal Injuries in Children
TerminatedNCT03147690
Start: 2017-11-01End: 2019-10-07Updated: 2021-06-11
Radiation-Free Technique for Evaluating Renal Scarring (RAFTERS)
NCT03653702
Start: 2023-10-01End: 2024-06-30Target: 70Updated: 2023-08-31
Contrast Ultrasound for Pediatric Trauma - Comparative Evaluation (CAPTURE Study)
CompletedNCT04718441
Start: 2021-05-10End: 2025-07-30Updated: 2025-10-03
Contrast-Enhanced Ultrasound and Shear Wave Elastography for the Treatment of Lymphedema
CompletedNCT05613946
Start: 2022-12-15End: 2024-06-30Updated: 2024-08-21
Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
Not yet recruitingNCT06329570
Start: 2024-07-01End: 2027-03-31Target: 10Updated: 2024-03-26
Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau
Not yet recruitingNCT06600880
Start: 2026-08-31End: 2027-12-31Target: 6Updated: 2025-05-11
Phase 2
Phase 3
Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141
CompletedNCT02522481
Start: 2015-09-24End: 2018-02-25Updated: 2021-06-11
Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142
CompletedNCT02552238
Start: 2015-10-12End: 2018-02-25Updated: 2021-07-07
Lumason® Infusion vs. Bolus Administrations
RecruitingNCT06400004
Start: 2024-07-10End: 2026-12-31Target: 106Updated: 2026-03-05